Abstract
The skin as a route of drug administration may offer numerous advantages despite its barrier nature which hinders most drugs to penetrate into and permeate across it. The main obstacle for drug permeation through the skin is the stratum corneum, the outermost layer of the skin. During the past decades, there has been a great interest in vesicular carriers as a tool to improve dermal and transdermal delivery of drugs. Vesicular carriers include liposomes, ultradeformable liposomes, ethosomes, and niosomes. These carrier systems are able to augment the skin drug permeation by enhancing drug solubilization in the formulation, controlling active drug release, improving drug partitioning into the skin, and fluidizing skin lipids. A wide variety of materials can be utilized to prepare vesicles, which are commonly composed of phospholipids (liposomes) or non-ionic surfactants (niosomes). Vesicle composition and method of preparation influence their physicochemical properties (size, charge, deformability) and therefore their efficacy as drug delivery systems. This chapter gives an overview of different vesicular carrier systems, with particular emphasis on the development of these delivery systems in light of comprehensive understanding of physicochemical properties of drug and delivery carriers, process and formulation variables, mechanism of skin delivery, recent technological improvements, and specific limitations.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CCPP:
-
Cationic cell-penetrating peptide
- CPP:
-
Critical packing parameter
- DDD:
-
Dermal drug delivery
- HLB:
-
Hydrophilic–lipophilic balance
- TDD:
-
Transdermal drug delivery
References
Abd El-Alim SH, Kassem AA, Basha M (2014) Proniosomes as a novel drug carrier system for buccal delivery of benzocaine. J Drug Deliv Sci Technol 24(5):452–458. https://doi.org/10.1016/S1773-2247(14)50087-1
Abdallah M, Sammour O, El-Ghamry H, Abu-Selem M (2013) Preparation and in-vitro evaluation of diclofenac sodium niosomal formulations. Int J Pharm Sci Res 4(5):1757–1765. https://doi.org/10.13040/IJPSR.0975-8232
Abdel Messih HA, Ishak RA, Geneidi AS, Mansour S (2017) Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation. Drug Dev Ind Pharm 43(6):958–971. https://doi.org/10.1080/03639045.2017.1287717
Abdelbary AA, AbouGhaly MH (2015) Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm 485(1-2):235–243. https://doi.org/10.1016/j.ijpharm.2015.03.020
Abdelkader H, Alani AW, Alany RG (2014) Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv 21(2):87–100. https://doi.org/10.3109/10717544.2013.838077
Abdellatif AA, Tawfeek HM (2016) Transfersomal nanoparticles for enhanced transdermal delivery of clindamycin. AAPS PharmSciTech 17(5):1067–1074. https://doi.org/10.1208/s12249-015-0441-7
Abdellatif MM, Khalil IA, Khalil MAF (2017) Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: in-vitro, ex-vivo and in-vivo evaluation. Int J Pharm 527(1-2):1–11. https://doi.org/10.1016/j.ijpharm.2017.05.029
Abdulbaqi IM, Darwis Y, Khan NA, Assi RA, Khan AA (2016) Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomed 11:2279–2304. https://doi.org/10.2147/IJN.S105016
Abidin L, Mujeeb M, Imam SS, Aqil M, Khurana D (2016) Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment. Drug Deliv 23(3):1079–1084. https://doi.org/10.3109/10717544.2014.945130
Agarwal S, Bakshi V, Vitta P, Raghuram A, Udupa N (2004) Effect of cholesterol content and surfactant HLB on vesicle properties of niosomes. Ind J Pharm Sci 66(1):121–123
Ahad A, Al-Saleh AA, Al-Mohizea AM, Al-Jenoobi FI, Raish M, Yassin AEB, Alam MA (2017) Formulation and characterization of Phospholipon 90 G and tween 80 based transfersomes for transdermal delivery of eprosartan mesylate. Pharm Dev Technol 23(8):787–793. https://doi.org/10.1080/10837450.2017.1330345
Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M (2013) Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. Int J Pharm 443(1-2):26–38. https://doi.org/10.1016/j.ijpharm.2013.01.011
Ahmed TA (2015) Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett-Burman design and characterization. J Liposome Res 25(1):1–10. https://doi.org/10.3109/08982104.2014.950276
Ahmed TA, El-Say KM, Aljaeid BM, Fahmy UA, Abd-Allah FI (2016) Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation. Int J Pharm 500(1-2):245–254. https://doi.org/10.1016/j.ijpharm.2016.01.017
Ahn B-N, Kim S-K, Shim C-K (1995) Proliposomes as an intranasal dosage form for the sustained delivery of propranolol. J Control Release 34(3):203–210. https://doi.org/10.1016/0168-3659(94)00114-A
Ainbinder D, Godin B, Touitou E (2016) Ethosomes: enhanced delivery of drugs to and across the Skin. In: Dragicevic N, Maibach HI (eds) Percutaneous penetration enhancers chemical methods in penetration enhancement: nanocarriers. Springer, Berlin/Heidelberg, pp 61–75
Ainbinder D, Paolino D, Fresta M, Touitou E (2010) Drug delivery applications with ethosomes. J Biomed Nanotechnol 6(5):558–568. https://doi.org/10.1166/jbn.2010.1152
Ainbinder D, Touitou E (2005) Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv 12(5):297–303. https://doi.org/10.1080/10717540500176910
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8(1):102. https://doi.org/10.1186/1556-276X-8-102
Al-Mahallawi AM, Abdelbary AA, Aburahma MH (2015) Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm 485(1-2):329–340. https://doi.org/10.1016/j.ijpharm.2015.03.033
Al Shuwaili AH, Rasool BK, Abdulrasool AA (2016) Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline. Eur J Pharm Biopharm 102:101–114. https://doi.org/10.1016/j.ejpb.2016.02.013
Alexander A, Dwivedi S, Ajazuddin GTK, Saraf S, Saraf S, Tripathi DK (2012) Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release 164(1):26–40. https://doi.org/10.1016/j.jconrel.2012.09.017
Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM (2011) Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405(1):142–152. https://doi.org/10.1016/j.ijpharm.2010.11.003
Ammar HO, Mohamed MI, Tadros MI, Fouly AA (2018) Transdermal delivery of ondansetron hydrochloride via bilosomal systems: in vitro, ex vivo, and in vivo characterization studies. AAPS PharmSciTech 19(5):2276–2287. https://doi.org/10.1208/s12249-018-1019-y
Antonietti M, Förster S (2003) Vesicles and liposomes: a self-assembly principle beyond lipids. Adv Mater 15(16):1323–1333. https://doi.org/10.1002/adma.200300010
Arafa MG, Ayoub BM (2017) DOE optimization of nano-based carrier of pregabalin as hydrogel: new therapeutic & chemometric approaches for controlled drug delivery systems. Sci Rep 7:41503. https://doi.org/10.1038/srep41503
Arora A, Prausnitz MR, Mitragotri S (2008) Micro-scale devices for transdermal drug delivery. Int J Pharm 364(2):227–236. https://doi.org/10.1016/j.ijpharm.2008.08.032
Arslan Azizoglu G, Tuncay Tanriverdi S, Aydin Kose F, Ballar Kirmizibayrak P, Ozer O (2017) Dual-prevention for UV-induced skin damage: incorporation of melatonin-loaded elastic niosomes into octyl methoxycinnamate pickering emulsions. AAPS PharmSciTech 18(8):2987–2998. https://doi.org/10.1208/s12249-017-0786-1
Avadhani KS, Manikkath J, Tiwari M, Chandrasekhar M, Godavarthi A, Vidya SM, Hariharapura RC, Kalthur G, Udupa N, Mutalik S (2017) Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Deliv 24(1):61–74. https://doi.org/10.1080/10717544.2016.1228718
Azeem A, Anwer MK, Talegaonkar S (2009) Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target 17(9):671–689. https://doi.org/10.3109/10611860903079454
Azeem A, Jain N, Iqbal Z, Ahmad FJ, Aqil M, Talegaonkar S (2008) Feasibility of proniosomes-based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation. Pharm Dev Technol 13(2):155–163. https://doi.org/10.1080/10837450701831211
Aziz DE, Abdelbary AA, Elassasy AI (2018) Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study. J Liposome Res:1–13. https://doi.org/10.1080/08982104.2018.1430831
Babaie S, Ghanbarzadeh S, Davaran S, Kouhsoltani M, Hamishehkar H (2015) Nanoethosomes for dermal delivery of lidocaine. Adv Pharm Bull 5(4):549–556. https://doi.org/10.15171/apb.2015.074
Badkar AV, Smith AM, Eppstein JA, Banga AK (2007) Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats. Pharm Res 24(7):1389–1395. https://doi.org/10.1007/s11095-007-9308-2
Bangham AD (1995) Surrogate cells or Trojan horses. The discovery of liposomes. Bioessays 17(12):1081–1088. https://doi.org/10.1002/bies.950171213
Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, Lopez-Quintela MA (2007) Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 127(7):1701–1712. https://doi.org/10.1038/sj.jid.5700733
Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14(2):101–114. https://doi.org/10.1016/S0928-0987(01)00167-1
Barry BW (2002) Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev 54(Suppl 1):S31–S40. https://doi.org/10.1016/S0169-409X(02)00113-8
Basha M, Abd El-Alim SH, Kassem AA, El Awdan S, Awad G (2015) Benzocaine loaded solid lipid nanoparticles: Formulation design, in vitro and in vivo evaluation of local anesthetic effect. Curr Drug Deliv 12(6):680–692. https://doi.org/10.2174/1567201812666150703115126
Batzri S, Korn ED (1973) Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 298(4):1015–1019
Behl CR, Flynn GL, Kurihara T, Harper N, Smith W, Higuchi WI, Ho NF, Pierson CL (1980) Hydration and percutaneous absorption: I. Influence of hydration on alkanol permeation through hairless mouse skin. J Invest Dermatol 75(4):346–352. https://doi.org/10.1111/1523-1747.ep12531118
Bennett WF, MacCallum JL, Tieleman DP (2009) Thermodynamic analysis of the effect of cholesterol on dipalmitoylphosphatidylcholine lipid membranes. J Am Chem Soc 131(5):1972–1978. https://doi.org/10.1021/ja808541r
Benson HA (2005) Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2(1):23–33. https://doi.org/10.2174/1567201052772915
Berenson GS, Burch GE (1951) Studies of diffusion of water through dead human skin: the effect of different environmental states and of chemical alterations of the epidermis1. Am J Trop Med Hyg 31(6):842–853. https://doi.org/10.4269/ajtmh.1951.s1-31.842
Betz G, Imboden R, Imanidis G (2001) Interaction of liposome formulations with human skin in vitro. Int J Pharm 229(1):117–129. https://doi.org/10.1016/S0378-5173(01)00824-9
Bhatia A, Kumar R, Katare OP (2004) Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci 7(2):252–259
Biswal S, Murthy P, Sahu J, Sahoo P, Amir F (2008) Vesicles of non-ionic surfactants (niosomes) and drug delivery potential. Int J Pharm Sci Nanotechnol 1(1):1–8
Blazek-Welsh AI, Rhodes DG (2001) SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharm Res 18(5):656–661. https://doi.org/10.1023/A:1011037527889
Bouwstra JA, Hofland HEJ (1994) Niosomes. In: Kreuter J (ed) Colloidal drug delivery systems, vol 66. Marcel Dekker Inc., New York/Basel/Hong Kong, pp 191–217
Bouwstra JA, Hofland HEJ, Spies F, Gooris GS, Junginger HE (1992) Changes in the structure of the human stratum corneum induced by liposomes. In: Braun-Falco O, Korting HC, Maibach HI (eds) Liposome dermatics: Griesbach conference. Springer, Berlin/Heidelberg, pp 121–136
Bragagni M, Scozzafava A, Mastrolorenzo A, Supuran CT, Mura P (2015) Development and ex vivo evaluation of 5-aminolevulinic acid-loaded niosomal formulations for topical photodynamic therapy. Int J Pharm 494(1):258–263. https://doi.org/10.1016/j.ijpharm.2015.08.036
Brinkhuis RP, Rutjes FPJT, van Hest JCM (2011) Polymeric vesicles in biomedical applications. Polym Chem 2(7):1449–1462. https://doi.org/10.1039/C1PY00061F
Carafa M, Marianecci C, Rinaldi F, Santucci E, Tampucci S, Monti D (2009) Span and Tween neutral and pH-sensitive vesicles: characterization and in vitro skin permeation. J Liposome Res 19(4):332–340. https://doi.org/10.3109/08982100903014994
Cevc G (1996) Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 13(3-4):257–388
Cevc G, Blume G (1992) Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta Biomembr 1104(1):226–232. https://doi.org/10.1016/0005-2736(92)90154-E
Cevc G, Blume G, Schätzlein A, Gebauer D, Paul A (1996) The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev 18(3):349–378. https://doi.org/10.1016/0169-409X(95)00091-K
Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G (1998) Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta Biomembr 1368(2):201–215. https://doi.org/10.1016/S0005-2736(97)00177-6
Cevc G, Mazgareanu S, Rother M (2008) Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. Int J Pharm 360(1-2):29–39. https://doi.org/10.1016/j.ijpharm.2008.01.051
Chandrashekar NS, Shobha Rani RH (2008) Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Ind J Pharm Sci 70(1):94–96. https://doi.org/10.4103/0250-474X.40340
Chen J, Lu WL, Gu W, Lu SS, Chen ZP, Cai BC (2013) Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert Opin Drug Deliv 10(6):845–856. https://doi.org/10.1517/17425247.2013.779252
Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L (2012) Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 17(5):5972–5987. https://doi.org/10.3390/molecules17055972
Chen ZX, Li B, Liu T, Wang X, Zhu Y, Wang L, Wang XH, Niu X, Xiao Y, Sun Q (2017) Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Eur J Pharm Sci 99:240–245. https://doi.org/10.1016/j.ejps.2016.12.026
Chiu C-W, Chang C-H, Yang Y-M (2013) Ethanol effects on the gelation behavior of α-tocopherol acetate-encapsulated ethosomes with water-soluble polymers. Colloid Polym Sci 291(6):1341–1352. https://doi.org/10.1007/s00396-012-2864-y
Choi MJ, Maibach HI (2005) Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 18(5):209–219
Crommelin DJA, Schreier H (1994) Liposomes. In: Kreuter J (ed) Colloidal drug delivery systems, vol 66. Marcel Dekker Inc., New York/Basel/Hong Kong, pp 73–190
Cronin MT, Dearden JC, Moss GP, Murray-Dickson G (1999) Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. Eur J Pharm Sci 7(4):325–330. https://doi.org/10.1016/S0928-0987(98)00041-4
Dayan N, Touitou E (2000) Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21(18):1879–1885. https://doi.org/10.1016/S0142-9612(00)00063-6
Deamer D, Bangham AD (1976) Large volume liposomes by an ether vaporization method. Biochim Biophys Acta 443(3):629–634
Dias MMR, Raghavan SL, Pellett MA, Hadgraft J (2003) The effect of β-cyclodextrins on the permeation of diclofenac from supersaturated solutions. Int J Pharm 263(1):173–181. https://doi.org/10.1016/S0378-5173(03)00366-1
Du J, O’Reilly RK (2009) Advances and challenges in smart and functional polymer vesicles. Soft Matter 5(19):3544–3561. https://doi.org/10.1039/B905635A
du Plessis J, Ramachandran C, Weiner N, Müller DG (1994) The influence of particle size of liposomes on the deposition of drug into skin. Int J Pharm 103(3):277–282. https://doi.org/10.1016/0378-5173(94)90178-3
Dubey V, Mishra D, Nahar M, Jain V, Jain NK (2010) Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomedicine 6(4):590–596. https://doi.org/10.1016/j.nano.2010.01.002
El-Laithy HM, Shoukry O, Mahran LG (2011) Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies. Eur J Pharm Biopharm 77(1):43–55. https://doi.org/10.1016/j.ejpb.2010.10.011
El-Ridy MS, Yehia SA, Mohsen AM, El-Awdan SA, Darwish AB (2017) Formulation of niosomal gel for enhanced transdermal lornoxicam delivery: in-vitro and in-vivo evaluation. Curr Drug Deliv. https://doi.org/10.2174/1567201814666170224141548
El Maghraby GM, Barry BW, Williams AC (2008) Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 34(4-5):203–222. https://doi.org/10.1016/j.ejps.2008.05.002
El Maghraby GM, Williams AC (2009) Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin Drug Deliv 6(2):149–163. https://doi.org/10.1517/17425240802691059
El Maghraby GM, Williams AC, Barry BW (1999) Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 51(10):1123–1134. https://doi.org/10.1211/0022357991776813
El Maghraby GM, Williams AC, Barry BW (2000a) Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 196(1):63–74. https://doi.org/10.1016/S0378-5173(99)00441-X
El Maghraby GM, Williams AC, Barry BW (2000b) Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 204(1-2):159–169. https://doi.org/10.1016/S0378-5173(00)00493-2
El Zaafarany GM, Awad GA, Holayel SM, Mortada ND (2010) Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397(1-2):164–172. https://doi.org/10.1016/j.ijpharm.2010.06.034
Elias PM, Friend DS (1975) The permeability barrier in mammalian epidermis. J Cell Biol 65(1):180–191. https://doi.org/10.1083/jcb.65.1.180
Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM (2007a) Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie 62(2):133–137. https://doi.org/10.1691/ph.2007.2.6082
Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM (2007b) Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332(1-2):1–16. https://doi.org/10.1016/j.ijpharm.2006.12.005
Erdő F, Hashimoto N, Karvaly G, Nakamichi N, Kato Y (2016) Critical evaluation and methodological positioning of the transdermal microdialysis technique. A review. J Control Release 233:147–161. https://doi.org/10.1016/j.jconrel.2016.05.035
Esposito E, Drechsler M, Huang N, Pavoni G, Cortesi R, Santonocito D, Puglia C (2016) Ethosomes and organogels for cutaneous administration of crocin. Biomed Microdevices 18(6):108. https://doi.org/10.1007/s10544-016-0134-3
Essa EA, Bonner MC, Barry BW (2002) Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery. J Pharm Pharmacol 54(11):1481–1490. https://doi.org/10.1211/002235702135
Fahmy AM, El-Setouhy DA, Ibrahim AB, Habib BA, Tayel SA, Bayoumi NA (2018) Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Drug Deliv 25(1):12–22. https://doi.org/10.1080/10717544.2017.1410262
Faisal W, Soliman GM, Hamdan AM (2016) Enhanced skin deposition and delivery of voriconazole using ethosomal preparations. J Liposome Res 25:1–25. https://doi.org/10.1080/08982104.2016.1239636
Fang J-Y, Hong C-T, Chiu W-T, Wang Y-Y (2001a) Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219(1):61–72. https://doi.org/10.1016/S0378-5173(01)00627-5
Fang J-Y, Yu S-Y, Wu P-C, Huang Y-B, Tsai Y-H (2001b) In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215(1):91–99. https://doi.org/10.1016/S0378-5173(00)00669-4
Farghaly DA, Aboelwafa AA, Hamza MY, Mohamed MI (2017) Topical delivery of fenoprofen calcium via elastic nano-vesicular spanlastics: optimization using experimental design and in vivo evaluation. AAPS PharmSciTech 18(8):2898–2909. https://doi.org/10.1208/s12249-017-0771-8
Feingold KR (2007) Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 48(12):2531–2546. https://doi.org/10.1194/jlr.R700013-JLR200
Fiala S, Jones SA, Brown MB (2010) A fundamental investigation into the effects of eutectic formation on transmembrane transport. Int J Pharm 393(1):68–73. https://doi.org/10.1016/j.ijpharm.2010.04.001
Finnin BC, Morgan TM (1999) Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci 88(10):955–958. https://doi.org/10.1021/js990154g
Foldvari M (2000) Non-invasive administration of drugs through the skin: challenges in delivery system design. Pharm Sci Technol Today 3(12):417–425. https://doi.org/10.1016/S1461-5347(00)00317-5
Foldvari M, Babiuk S, Badea I (2006) DNA delivery for vaccination and therapeutics through the skin. Curr Drug Deliv 3(1):17–28. https://doi.org/10.2174/156720106775197493
Foldvari M, Gesztes A, Mezei M (1990) Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J Microencapsul 7(4):479–489. https://doi.org/10.3109/02652049009040470
Foldvari M, Gesztes A, Mezei M, Cardinal L, Kowalczyk I, Behl M (1993) Topical liposomal local anesthetics: design, optimization and evaluation of formulations. Drug Dev Ind Pharm 19(19):2499–2517. https://doi.org/10.3109/03639049309047198
Fresta M, Puglisi G (1996) Application of liposomes as potential cutaneous drug delivery systems. in vitro and in vivo investigation with radioactively labelled vesicles. J Drug Target 4(2):95–101. https://doi.org/10.3109/10611869609046267
Garg BJ, Garg NK, Beg S, Singh B, Katare OP (2016) Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. J Drug Target 24(3):233–246. https://doi.org/10.3109/1061186x.2015.1070855
Garg M, Mishra D, Agashe H, Jain NK (2006) Ethinylestradiol-loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics. J Pharm Pharmacol 58(4):459–468. https://doi.org/10.1211/jpp.58.4.0005
Garg T, Bilandi A, Kapoor B (2012a) Evolutionary approaches for drug and gene delivery by micro and nano magnetic carriers. Indo-global Res J Pharm Sci 2(1):182–189
Garg T, Bilandi A, Kapoor B, Kumar S, Joshi R (2011) Organogels: advanced and novel drug delivery system. Int Res J Pharm 2(12):15–21
Garg T, Chanana A, Sharma G (2012b) Pulsatile drug delivery systems: pulsincap system. IOSR J Pharm 2:338–339
Garg T, Goyal AK (2014) Liposomes: targeted and controlled delivery system. Drug Deliv Lett 4(1):62–71. https://doi.org/10.2174/22103031113036660015
Garg V, Singh H, Bhatia A, Raza K, Singh SK, Singh B, Beg S (2017) Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment. AAPS PharmSciTech 18(1):58–71. https://doi.org/10.1208/s12249-016-0489-z
Gebicki JM, Hicks M (1973) Ufasomes are stable particles surrounded by unsaturated fatty acid membranes. Nature 243:232. https://doi.org/10.1038/243232a0
Gershkovich P, Wasan KM, Barta CA (2008) A review of the application of lipid-based systems in systemic, dermal/transdermal, and ocular drug delivery. Crit Rev Ther Drug Carrier Syst 25(6):545–584. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v25.i6.20
Giannos SA (2014) Skin microporation: strategies to enhance and expand transdermal drug delivery. J Drug Deliv Sci Technol 24(3):293–299. https://doi.org/10.1016/S1773-2247(14)50048-2
Giannos SA (2015) Identifying present challenges to reliable future transdermal drug delivery products. Ther Deliv 6(9):1033–1041. https://doi.org/10.4155/tde.15.62
Gillet A, Compere P, Lecomte F, Hubert P, Ducat E, Evrard B, Piel G (2011a) Liposome surface charge influence on skin penetration behaviour. Int J Pharm 411(1-2):223–231. https://doi.org/10.1016/j.ijpharm.2011.03.049
Gillet A, Lecomte F, Hubert P, Ducat E, Evrard B, Piel G (2011b) Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm 79(1):43–53. https://doi.org/10.1016/j.ejpb.2011.01.011
Godin B, Touitou E (2003) Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 20(1):40. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v20.i1.20
Godin B, Touitou E (2004) Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release 94(2-3):365–379. https://doi.org/10.1016/j.jconrel.2003.10.014
Godin B, Touitou E, Rubinstein E, Athamna A, Athamna M (2005) A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J Antimicrob Chemother 55(6):989–994. https://doi.org/10.1093/jac/dki125
Green PG (1996) Iontophoretic delivery of peptide drugs. J Control Release 41(1):33–48. https://doi.org/10.1016/0168-3659(96)01354-5
Gregoriadis G, Florence AT (1993) Liposomes in drug delivery. Drugs 45(1):15–28. https://doi.org/10.2165/00003495-199345010-00003
Grice JE, Prow TW, Kendall MAF, Roberts MS (2012) Electrical and physical methods of skin penetration enhancement. In: Benson HAE, Watkinson AC (eds) Topical and transdermal drug delivery: principles and practice. Wiley, Hoboken, pp 43–65
Guinedi AS, Mortada ND, Mansour S, Hathout RM (2005) Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306(1):71–82. https://doi.org/10.1016/j.ijpharm.2005.09.023
Gupta A, Prajapati SK, Balamurugan M, Singh M, Bhatia D (2007) Design and development of a proniosomal transdermal drug delivery system for captopril. Tropical J Pharm Res 6(2):687–693. https://doi.org/10.4314/tjpr.v6i2.14647
Gurrapu A, Jukanti R, Bobbala SR, Kanuganti S, Jeevana JB (2012) Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol 23(5):583–590. https://doi.org/10.1016/j.apt.2011.06.005
Guy RH, Hadgraft J, Bucks DA (1987) Transdermal drug delivery and cutaneous metabolism. Xenobiotica 17(3):325–343. https://doi.org/10.3109/00498258709043943
Hadgraft J (2001) Modulation of the barrier function of the skin. Skin Pharmacol Physiol 14(Suppl 1):72–81. https://doi.org/10.1159/000056393
Hasanovic A, Hollick C, Fischinger K, Valenta C (2010) Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers. Eur J Pharm Biopharm 75(2):148–153. https://doi.org/10.1016/j.ejpb.2010.03.014
Hayden CG, Cross SE, Anderson C, Saunders NA, Roberts MS (2005) Sunscreen penetration of human skin and related keratinocyte toxicity after topical application. Skin Pharmacol Physiol 18(4):170–174. https://doi.org/10.1159/000085861
Hirsch M, Ziroli V, Helm M, Massing U (2009) Preparation of small amounts of sterile siRNA-liposomes with high entrapping efficiency by dual asymmetric centrifugation (DAC). J Control Release 135(1):80–88. https://doi.org/10.1016/j.jconrel.2008.11.029
Honeywell-Nguyen PL, Bouwstra JA (2005) Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2(1):67–74. https://doi.org/10.1016/j.ddtec.2005.05.003
Hood RR, Kendall EL, Junqueira M, Vreeland WN, Quezado Z, Finkel JC, DeVoe DL (2014) Microfluidic-enabled liposomes elucidate size-dependent transdermal transport. PLoS One 9(3):e92978. https://doi.org/10.1371/journal.pone.0092978
Hu C, Rhodes DG (2000) Proniosomes: a novel drug carrier preparation. Int J Pharm 206(1-2):110–122. https://doi.org/10.1016/S0378-5173(00)00513-5
Hua S (2015) Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front Pharmacol 6:219. https://doi.org/10.3389/fphar.2015.00219
Hwang B-Y, Jung B-H, Chung S-J, Lee M-H, Chang-Koo S (1997) In vitro skin permeation of nicotine from proliposomes. J Control Release 49(2):177–184. https://doi.org/10.1016/S0168-3659(97)00073-4
Iervolino M, Cappello B, Raghavan SL, Hadgraft J (2001) Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int J Pharm 212(1):131–141. https://doi.org/10.1016/S0378-5173(00)00603-7
Iizhar SA, Syed IA, Satar R, Ansari SA (2016) In vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochloride. J Adv Res 7(3):453–461. https://doi.org/10.1016/j.jare.2016.03.003
Ioele G, Tavano L, De Luca M, Ragno G, Picci N, Muzzalupo R (2015) Photostability and ex-vivo permeation studies on diclofenac in topical niosomal formulations. Int J Pharm 494(1):490–497. https://doi.org/10.1016/j.ijpharm.2015.08.053
Jaafar-Maalej C, Diab R, Andrieu V, Elaissari A, Fessi H (2010) Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res 20(3):228–243. https://doi.org/10.3109/08982100903347923
Jacob S, Nair AB, Al-Dhubiab BE (2017) Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition. J Liposome Res 27(4):283–292. https://doi.org/10.1080/08982104.2016.1224897
Jahn A, Vreeland WN, DeVoe DL, Locascio LE, Gaitan M (2007) Microfluidic directed formation of liposomes of controlled size. Langmuir 23(11):6289–6293. https://doi.org/10.1021/la070051a
Jain S, Jain P, Umamaheshwari RB, Jain NK (2003) Transfersomes – a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29(9):1013–1026. https://doi.org/10.1081/DDC-120025458
Jain S, Jain V, Mahajan SC (2014) Lipid based vesicular drug delivery systems. Advances in Pharmaceutics 2014:12. https://doi.org/10.1155/2014/574673
Jain S, Patel N, Madan P, Lin S (2015) Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Pharm Dev Technol 20(4):473–489. https://doi.org/10.3109/10837450.2014.882939
Jain S, Patel N, Shah MK, Khatri P, Vora N (2017) Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J Pharm Sci 106(2):423–445. https://doi.org/10.1016/j.xphs.2016.10.001
Jain S, Umamaheshwari R, Bhadra D, Jain N (2004) Ethosomes: a novel vesicular carrier for enhanced transdermal delivery of an antiHIV agent. Ind J Pharm Sci 66(1):72
Jamal M, Imam SS, Aqil M, Amir M, Mir SR, Mujeeb M (2015) Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems. Int Immunopharmacol 29(2):361–369. https://doi.org/10.1016/j.intimp.2015.10.029
Jangdey MS, Gupta A, Saraf S, Saraf S (2017) Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation. Artif Cells Nanomed Biotechnol 45(7):1452–1462. https://doi.org/10.1080/21691401.2016.1247850
Jepps OG, Dancik Y, Anissimov YG, Roberts MS (2013) Modeling the human skin barrier – towards a better understanding of dermal absorption. Adv Drug Deliv Rev 65(2):152–168. https://doi.org/10.1016/j.addr.2012.04.003
Kakkar S, Kaur IP (2011) Spanlastics – a novel nanovesicular carrier system for ocular delivery. Int J Pharm 413(1-2):202–210. https://doi.org/10.1016/j.ijpharm.2011.04.027
Kalbitz J, Neubert R, Wohlrab W (1996) Modulation of drug penetration in the skin. Pharmazie 51(9):619–637
Kang L, Yap CW, Lim PF, Chen YZ, Ho PC, Chan YW, Wong GP, Chan SY (2007) Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin. J Control Release 120(3):211–219. https://doi.org/10.1016/j.jconrel.2007.05.006
Kanikkannan N, Kandimalla K, Lamba SS, Singh M (2000) Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 7(6):593–608. https://doi.org/10.2174/0929867003374840
Karami Z, Hamidi M (2016) Cubosomes: remarkable drug delivery potential. Drug Discov Today 21(5):789–801. https://doi.org/10.1016/j.drudis.2016.01.004
Kassem AA, Abd El-Alim SH, Asfour MH (2017) Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition. Int J Pharm 517(1-2):256–268. https://doi.org/10.1016/j.ijpharm.2016.12.018
Katahira N, Murakami T, Kugai S, Yata N, Takano M (1999) Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes. J Drug Target 6(6):405–414. https://doi.org/10.3109/10611869908996847
Kato A, Ishibashi Y, Miyake Y (1987) Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol 39(5):399–400. https://doi.org/10.1111/j.2042-7158.1987.tb03407.x
Kaur IP, Garg A, Singla AK, Aggarwal D (2004) Vesicular systems in ocular drug delivery: an overview. Int J Pharm 269(1):1–14. https://doi.org/10.1016/j.ijpharm.2003.09.016
Keith A, Snipes W (1982) Phospholipids as moisturizing agents. In: Frost P, Horwitz SN (eds) Principles of cosmetics for the dermatologist. The CV Mosby Company, St. Louis, pp 59–69
Kemken J, Ziegler A, Müller BW (1992) Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle. Pharm Res 9(4):554–558. https://doi.org/10.1023/a:1015856800653
Khan NR, Wong TW (2016) Microwave-aided skin drug penetration and retention of 5-fluorouracil-loaded ethosomes. Expert Opin Drug Deliv 13(9):1209–1219. https://doi.org/10.1080/17425247.2016.1193152
Kim YC, Lee SH, Choi WH, Choi HJ, Goo TW, Lee JH, Quan FS (2016) Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection. J Drug Target 24(10):943–951. https://doi.org/10.3109/1061186X.2016.1159213
Kirjavainen M, Urtti A, Jääskeläinen I, Marjukka Suhonen T, Paronen P, Valjakka-Koskela R, Kiesvaara J, Mönkkönen J (1996) Interaction of liposomes with human skin in vitro – the influence of lipid composition and structure. Biochim Biophys Acta Lipid Lipid Metabol 1304(3):179–189. https://doi.org/10.1016/S0005-2760(96)00126-9
Kisak ET, Coldren B, Evans CA, Boyer C, Zasadzinski JA (2004) The vesosome – a multicompartment drug delivery vehicle. Curr Med Chem 11(2):199–219. https://doi.org/10.2174/0929867043456197
Kitagawa S, Kasamaki M (2006) Enhanced delivery of retinoic acid to skin by cationic liposomes. Chem Pharm Bull 54(2):242–244. https://doi.org/10.1248/cpb.54.242
Klareskog L, Tjernlund U, Forsum U, Peterson PA (1977) Epidermal langerhans cells express Ia antigens. Nature 268(5617):248–250. https://doi.org/10.1038/268248a0
Korting HC, Stolz W, Schmid MH, Maierhofer G (1995) Interaction of liposomes with human epidermis reconstructed in vitro. Br J Dermatol 132(4):571–579. https://doi.org/10.1111/j.1365-2133.1995.tb08713.x
Korting HC, Zienicke H, Schafer-Korting M, Braun-Falco O (1990) Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 39(4):349–351. https://doi.org/10.1007/BF00315408
Kulkarni CV, Wachter W, Iglesias-Salto G, Engelskirchen S, Ahualli S (2011) Monoolein: a magic lipid? Phys Chem Chem Phys 13(8):3004–3021. https://doi.org/10.1039/C0CP01539C
Kulkarni SB, Betageri GV, Singh M (1995) Factors affecting microencapsulation of drugs in liposomes. J Microencapsul 12(3):229–246. https://doi.org/10.3109/02652049509010292
Kumar A, Pathak K, Bali V (2012) Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov Today 17(21-22):1233–1241. https://doi.org/10.1016/j.drudis.2012.06.013
Kumar GP, Rajeshwarrao P (2011) Nonionic surfactant vesicular systems for effective drug delivery – an overview. Acta Pharm Sinica B 1(4):208–219. https://doi.org/10.1016/j.apsb.2011.09.002
Kwon SS, Kim SY, Kong BJ, Kim KJ, Noh GY, Im NR, Lim JW, Ha JH, Kim J, Park SN (2015) Cell penetrating peptide conjugated liposomes as transdermal delivery system of Polygonum aviculare L. extract. Int J Pharm 483(1):26–37. https://doi.org/10.1016/j.ijpharm.2015.01.030
Lademann J, Otberg N, Richter H, Weigmann HJ, Lindemann U, Schaefer H, Sterry W (2001) Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol 14(Suppl 1):17–22. https://doi.org/10.1159/000056385
Laouini A, Jaafar-Maalej C, Limayem-Blouza I, Sfar S, Charcosset C, Fessi H (2012) Preparation, characterization and applications of liposomes: state of the art. Journal of colloid Science and Biotechnology 1(2):147–168
Latsch S, Selzer T, Fink L, Kreuter J (2003) Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy. Eur J Pharm Biopharm 56(1):43–52. https://doi.org/10.1016/S0939-6411(03)00042-0
Lee EH, Kim A, Oh YK, Kim CK (2005) Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26(2):205–210. https://doi.org/10.1016/j.biomaterials.2004.02.020
Lee JS, Feijen J (2012) Polymersomes for drug delivery: design, formation and characterization. J Control Release 161(2):473–483. https://doi.org/10.1016/j.jconrel.2011.10.005
Lesoin L, Boutin O, Crampon C, Badens E (2011a) CO2/water/surfactant ternary systems and liposome formation using supercritical CO2: a review. Colloids Surf A Physicochem Eng Asp 377(1):1–14. https://doi.org/10.1016/j.colsurfa.2011.01.027
Lesoin L, Crampon C, Boutin O, Badens E (2011b) Preparation of liposomes using the supercritical anti-solvent (SAS) process and comparison with a conventional method. J Supercritical Fluids 57(2):162–174. https://doi.org/10.1016/j.supflu.2011.01.006
Levy R, Okada S, Beziat V, Moriya K, Liu C, Chai LY, Migaud M, Hauck F, Al Ali A, Cyrus C, Vatte C, Patiroglu T, Unal E, Ferneiny M, Hyakuna N, Nepesov S, Oleastro M, Ikinciogullari A, Dogu F, Asano T, Ohara O, Yun L, Della Mina E, Bronnimann D, Itan Y, Gothe F, Bustamante J, Boisson-Dupuis S, Tahuil N, Aytekin C, Salhi A, Al Muhsen S, Kobayashi M, Toubiana J, Abel L, Li X, Camcioglu Y, Celmeli F, Klein C, AlKhater SA, Casanova JL, Puel A (2016) Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci USA 113(51):E8277–E8285. https://doi.org/10.1073/pnas.1618300114
Li G, Fan Y, Fan C, Li X, Wang X, Li M, Liu Y (2012) Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm 82(1):49–57. https://doi.org/10.1016/j.ejpb.2012.05.011
Li J, Wang X, Zhang T, Wang C, Huang Z, Luo X, Deng Y (2015a) A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci 10(2):81–98. https://doi.org/10.1016/j.ajps.2014.09.004
Li JC, Zhu N, Zhu JX, Zhang WJ, Zhang HM, Wang QQ, Wu XX, Wang X, Zhang J, Hao JF (2015b) Self-assembled cubic liquid crystalline nanoparticles for transdermal delivery of paeonol. Med Sci Monit 21:3298–3310. https://doi.org/10.12659/MSM.894484
Li K, Gao S, Tian B, Shi Y, Lv Q, Han J (2017) Formulation optimization and in vitro and in vivo evaluation of lornoxicam ethosomal gels with penetration enhancers. Curr Drug Deliv. https://doi.org/10.2174/1567201815666171207163010
Limsuwan T, Amnuaikit T (2012) Development of ethosomes containing mycophenolic acid. Procedia Chem 4(Suppl C):328–335. https://doi.org/10.1016/j.proche.2012.06.046
Limsuwan T, Boonme P, Khongkow P, Amnuaikit T (2017) Ethosomes of phenylethyl resorcinol as vesicular delivery system for skin lightening applications. BioMed Res Int 2017:12. https://doi.org/10.1155/2017/8310979
Liu X, Liu H, Liu J, He Z, Ding C, Huang G, Zhou W, Zhou L (2011) Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo. Int J Nanomed 6:241–247. https://doi.org/10.2147/IJN.S16044
Lopez-Pinto JM, Gonzalez-Rodriguez ML, Rabasco AM (2005) Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298(1):1–12. https://doi.org/10.1016/j.ijpharm.2005.02.021
Lutton ES (1965) Phase behavior of aqueous systems of monoglycerides. J Am Oil Chem Soc 42(12):1068–1070. https://doi.org/10.1007/bf02636909
Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR (2012) Niosomes: novel sustained release nonionic stable vesicular systems – an overview. Adv Colloid Interface Sci 183-184:46–54. https://doi.org/10.1016/j.cis.2012.08.002
Manconi M, Sinico C, Valenti D, Lai F, Fadda AM (2006) Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. International Journal of Pharmaceutics 311(1):11–19. https://doi.org/10.1016/j.ijpharm.2005.11.045
Manosroi A, Chankhampan C, Manosroi W, Manosroi J (2013) Transdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatment. Eur J Pharm Sci 48(3):474–483. https://doi.org/10.1016/j.ejps.2012.12.010
Manosroi A, Jantrawut P, Akazawa H, Akihisa T, Manosroi W, Manosroi J (2011) Transdermal absorption enhancement of gel containing elastic niosomes loaded with gallic acid from Terminalia chebula galls. Pharm Biol 49(6):553–562. https://doi.org/10.3109/13880209.2010.528432
Manosroi A, Jantrawut P, Manosroi J (2008) Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 360(1-2):156–163. https://doi.org/10.1016/j.ijpharm.2008.04.033
Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito S, Carafa M (2014) Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci 205:187–206. https://doi.org/10.1016/j.cis.2013.11.018
Martin GP, Lloyd AW (1992) Basic principles of liposomes for drug use. In: Braun-Falco O, Korting HC, Maibach HI (eds) Liposome dermatics: Griesbach conference. Springer, Berlin/Heidelberg, pp 20–26
Marto J, Vitor C, Guerreiro A, Severino C, Eleuterio C, Ascenso A, Simoes S (2016) Ethosomes for enhanced skin delivery of griseofulvin. Colloids Surf B Biointerf 146:616–623. https://doi.org/10.1016/j.colsurfb.2016.07.021
Marwah H, Garg T, Goyal AK, Rath G (2016) Permeation enhancer strategies in transdermal drug delivery. Drug Deliv 23(2):564–578. https://doi.org/10.3109/10717544.2014.935532
Massignani M, Lomas H, Battaglia G (2010) Polymersomes: a synthetic biological approach to encapsulation and delivery. In: Caruso F (ed) Modern techniques for nano- and microreactors/-reactions. Springer, Berlin/Heidelberg, pp 115–154
Massing U, Cicko S, Ziroli V (2008) Dual asymmetric centrifugation (DAC)—a new technique for liposome preparation. J Control Release 125(1):16–24. https://doi.org/10.1016/j.jconrel.2007.09.010
McKenzie A, Stoughton R (1962) Method for comparing percutaneous absorption of steroids. Arch Dermatol 86(5):608–610. https://doi.org/10.1001/archderm.1962.01590110044005
Megwa SA, Cross SE, Benson HAE, Roberts MS (2000a) Ion-pair formation as a strategy to enhance topical delivery of salicylic acid. J Pharm Pharmacol 52(8):919–928. https://doi.org/10.1211/0022357001774804
Megwa SA, Cross SE, Whitehouse MW, Benson HAE, Roberts MS (2000b) Effect of ion pairing with alkylamines on the in-vitro dermal penetration and local tissue disposition of salicylates. J Pharm Pharmacol 52(8):929–940. https://doi.org/10.1211/0022357001774813
Melnik B, Hollmann J, Plewig G (1988) Decreased stratum corneum ceramides in atopic individuals—a pathobiochemical factor in xerosis? Br J Dermatol 119(4):547–548. https://doi.org/10.1111/j.1365-2133.1988.tb03262.x
Meng F, Zhong Z (2011) Polymersomes spanning from nano- to microscales: advanced vehicles for controlled drug delivery and robust vesicles for virus and cell mimicking. J Phys Chem Lett 2(13):1533–1539. https://doi.org/10.1021/jz200007h
Mezei M, Gulasekharam V (1980) Liposomes - a selective drug delivery system for the topical route of administration I. Lotion dosage form. Life Sci 26(18):1473–1477. https://doi.org/10.1016/0024-3205(80)90268-4
Mezei M, Gulasekharam V (1982) Liposomes—a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 34(7):473–474. https://doi.org/10.1111/j.2042-7158.1982.tb04767.x
Michaels AS, Chandrasekaran SK, Shaw JE (1975) Drug permeation through human skin: theory and invitro experimental measurement. AIChE Journal 21(5):985–996. https://doi.org/10.1002/aic.690210522
Mishra V, Mahor S, Rawat A, Dubey P, Gupta PN, Singh P, Vyas SP (2006) Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine 24(27):5559–5570. https://doi.org/10.1016/j.vaccine.2006.04.030
Mitragotri S (2005) Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nature Rev Drug Discov 4:255. https://doi.org/10.1038/nrd1662
Mittal R, Sharma A, Arora S (2013) Ufasomes mediated cutaneous delivery of dexamethasone: formulation and evaluation of anti-inflammatory activity by carrageenin-induced rat paw edema model. J Pharm 2013:12. https://doi.org/10.1155/2013/680580
Moghassemi S, Hadjizadeh A (2014) Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release 185(Suppl C):22–36. https://doi.org/10.1016/j.jconrel.2014.04.015
Mohammed MI, Makky AM, Teaima MH, Abdellatif MM, Hamzawy MA, Khalil MA (2016) Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study. Drug Deliv 23(5):1558–1564. https://doi.org/10.3109/10717544.2015.1013200
Mokhtar M, Sammour OA, Hammad MA, Megrab NA (2008) Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361(1):104–111. https://doi.org/10.1016/j.ijpharm.2008.05.031
Montis C, Castroflorio B, Mendozza M, Salvatore A, Berti D, Baglioni P (2015) Magnetocubosomes for the delivery and controlled release of therapeutics. J Colloid Interface Sci 449(Suppl C):317–326. https://doi.org/10.1016/j.jcis.2014.11.056
Morigaki K, Walde P (2007) Fatty acid vesicles. Curr Opin Colloid Interface Sci 12(2):75–80. https://doi.org/10.1016/j.cocis.2007.05.005
Morrow D, McCarron P, Woolfson A, Donnelly R (2007) Innovative strategies for enhancing topical and transdermal drug delivery. The Open Drug Deliv J 1:36–59. https://doi.org/10.2174/1874126600701010036
Morsi NM, Abdelbary GA, Ahmed MA (2014) Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm 86(2):178–189. https://doi.org/10.1016/j.ejpb.2013.04.018
Morsi NM, Aboelwafa AA, Dawoud MH (2016) Improved bioavailability of timolol maleate via transdermal transfersomal gel: statistical optimization, characterization, and pharmacokinetic assessment. J Adv Res 7(5):691–701. https://doi.org/10.1016/j.jare.2016.07.003
Moser K, Kriwet K, Froehlich C, Naik A, Kalia YN, Guy RH (2001a) Permeation enhancement of a highly lipophilic drug using supersaturated systems. J Pharm Sci 90(5):607–616. https://doi.org/10.1002/1520-6017(200105)90:5<607::AID-JPS1017>3.0.CO;2-B
Moser K, Kriwet K, Kalia YN, Guy RH (2001b) Enhanced skin permeation of a lipophilic drug using supersaturated formulations. J Control Release 73(2):245–253. https://doi.org/10.1016/S0168-3659(01)00290-5
Mujica Ascencio S, Choe C, Meinke MC, Muller RH, Maksimov GV, Wigger-Alberti W, Lademann J, Darvin ME (2016) Confocal Raman microscopy and multivariate statistical analysis for determination of different penetration abilities of caffeine and propylene glycol applied simultaneously in a mixture on porcine skin ex vivo. Eur J Pharm Biopharm 104:51–58. https://doi.org/10.1016/j.ejpb.2016.04.018
Mujoriya RZ, Bodla R (2011) Niosomes–challenge in preparation for pharmaceutical scientist. Int J App Pharm 3(3):11–15
Müller M, Mackeben S, Müller-Goymann CC (2004) Physicochemical characterisation of liposomes with encapsulated local anaesthetics. Int J Pharm 274(1):139–148. https://doi.org/10.1016/j.ijpharm.2004.01.015
Murgia S, Falchi AM, Meli V, Schillén K, Lippolis V, Monduzzi M, Rosa A, Schmidt J, Talmon Y, Bizzarri R, Caltagirone C (2015) Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications. Colloids Surf B Biointerfaces 129(Suppl C):87–94. https://doi.org/10.1016/j.colsurfb.2015.03.025
Naeff R (1996) Feasibility of topical liposome drugs produced on an industrial scale. Adv Drug Deliv Rev 18(3):343–347. https://doi.org/10.1016/0169-409X(95)00080-Q
Naik A, Pechtold LARM, Potts RO, Guy RH (1995) Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J Control Release 37(3):299–306. https://doi.org/10.1016/0168-3659(95)00088-7
Nawaz M, Abbasi MW, Hisaindee S (2016) Synthesis, characterization, anti-bacterial, anti-fungal and nematicidal activities of 2-amino-3-cyanochromenes. J Photochem Photobiol B 164:160–163. https://doi.org/10.1016/j.jphotobiol.2016.09.032
Nemanic MK, Elias PM (1980) In situ precipitation: a novel cytochemical technique for visualization of permeability pathways in mammalian stratum corneum. J Histochem Cytochem 28(6):573–578. https://doi.org/10.1177/28.6.7190175
Oberli MA, Schoellhammer CM, Langer R, Blankschtein D (2014) Ultrasound-enhanced transdermal delivery: recent advances and future challenges. Ther Deliv 5(7):843–857. https://doi.org/10.4155/tde.14.32
Oesch F, Fabian E, Oesch-Bartlomowicz B, Werner C, Landsiedel R (2007) Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev 39(4):659–698. https://doi.org/10.1080/03602530701690366
Oh YK, Kim MY, Shin JY, Kim TW, Yun MO, Yang SJ, Choi SS, Jung WW, Kim JA, Choi HG (2006) Skin permeation of retinol in Tween 20-based deformable liposomes: in-vitro evaluation in human skin and keratinocyte models. J Pharm Pharmacol 58(2):161–166. https://doi.org/10.1211/jpp.58.2.0002
Otake K, Shimomura T, Goto T, Imura T, Furuya T, Yoda S, Takebayashi Y, Sakai H, Abe M (2006) Preparation of liposomes using an improved supercritical reverse phase evaporation method. Langmuir 22(6):2543–2550. https://doi.org/10.1021/la051654u
Otberg N, Patzelt A, Rasulev U, Hagemeister T, Linscheid M, Sinkgraven R, Sterry W, Lademann J (2008) The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol 65(4):488–492. https://doi.org/10.1111/j.1365-2125.2007.03065.x
Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J (2004) Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 122(1):14–19. https://doi.org/10.1046/j.0022-202X.2003.22110.x
Paleos CM, Tsiourvas D, Sideratou Z, Pantos A (2013) Formation of artificial multicompartment vesosome and dendrosome as prospected drug and gene delivery carriers. J Control Release 170(1):141–152. https://doi.org/10.1016/j.jconrel.2013.05.011
Pandey V, Golhani D, Shukla R (2015) Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug Deliv 22(8):988–1002. https://doi.org/10.3109/10717544.2014.889777
Paolino D, Cosco D, Cilurzo F, Trapasso E, Morittu VM, Celia C, Fresta M (2012) Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles. J Control Release 162(1):143–151. https://doi.org/10.1016/j.jconrel.2012.05.050
Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M (2005) Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 106(1-2):99–110. https://doi.org/10.1016/j.jconrel.2005.04.007
Pardakhty A, Moazeni E (2013) Nano-niosomes in drug, vaccine and gene delivery: a rapid overview. Nanomed J 1(1):1–12. https://doi.org/10.22038/nmj.2013.697
Pardakhty A, Varshosaz J, Rouholamini A (2007) In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328(2):130–141. https://doi.org/10.1016/j.ijpharm.2006.08.002
Parnami N, Garg T, Rath G, Goyal AK (2014) Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol 42(6):406–412. https://doi.org/10.3109/21691401.2013.837474
Patel D, Jani R, Patel C (2011) Ufasomes: a vesicular drug delivery. Systematic Rev Pharm 2(2):72. https://doi.org/10.4103/0975-8453.86290
Patel KK, Kumar P, Thakkar HP (2012) Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech 13(4):1502–1510. https://doi.org/10.1208/s12249-012-9871-7
Patel N, Jain S, Lin S (2016a) Transdermal iontophoretic delivery of tacrine hydrochloride: correlation between in vitro permeation and in vivo performance in rats. Int J Pharm 513(1-2):393–403. https://doi.org/10.1016/j.ijpharm.2016.09.038
Patel N, Jain S, Madan P, Lin S (2015) Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride. Pharm Dev Technol 20(4):442–457. https://doi.org/10.3109/10837450.2013.879886
Patel N, Jain S, Madan P, Lin S (2016b) Application of design of experiments for formulation development and mechanistic evaluation of iontophoretic tacrine hydrochloride delivery. Drug Dev Ind Pharm 42(11):1894–1902. https://doi.org/10.1080/03639045.2016.1181646
Patel TN (2013) Preparation and evaluation of imiquimod loaded liposomal dispersion: part-I. J Biomed Pharm Res 2(2):56–62
Pathak K, Sharma V, Sharma M (2016) Optimization, in vitro cytotoxicity and penetration capability of deformable nanovesicles of paclitaxel for dermal chemotherapy in Kaposi sarcoma. Artif Cells Nanomed Biotechnol 44(7):1671–1683. https://doi.org/10.3109/21691401.2015.1080169
Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL (2010) Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 1(1):109–131. https://doi.org/10.4155/tde.10.16
Payne NI, Browning I, Hynes CA (1986a) Characterization of proliposomes. J Pharm Sci 75(4):330–333. https://doi.org/10.1002/jps.2600750403
Payne NI, Timmins P, Ambrose CV, Ward MD, Ridgway F (1986b) Proliposomes: a novel solution to an old problem. J Pharm Sci 75(4):325–329. https://doi.org/10.1002/jps.2600750402
Pegoraro C, MacNeil S, Battaglia G (2011) Polymersome macromolecule delivery across intact human skin. Tech Proc NSTI Nanotechnol Conf and Expo, NSTI-Nanotech 3:428–431
Pegoraro C, MacNeil S, Battaglia G (2012) Transdermal drug delivery: from micro to nano. Nanoscale 4(6):1881–1894. https://doi.org/10.1039/C2NR11606E
Pellett MA, Davis AF, Hadgraft J (1994) Effect of supersaturation on membrane transport: 2. Piroxicam. Int J Pharm 111(1):1–6. https://doi.org/10.1016/0378-5173(94)90395-6
Pellett MA, Roberts MS, Hadgraft J (1997) Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int J Pharm 151(1):91–98. https://doi.org/10.1016/S0378-5173(97)04897-7
Peng X, Zhou Y, Han K, Qin L, Dian L, Li G, Pan X, Wu C (2015) Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. Drug Des Devel Ther 9:4209–4218. https://doi.org/10.2147/dddt.s86370
Perumal O, Murthy SN, Kalia YN (2013) Turning theory into practice: the development of modern transdermal drug delivery systems and future trends. Skin Pharmacol Physiol 26(4-6):331–342. https://doi.org/10.1159/000351815
Pirvu CD, Hlevca C, Ortan A, Prisada R (2010) Elastic vesicles as drugs carriers through the skin. Farmacia 58(2):128–135
Potts RO, Guy RH (1995) A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm Res 12(11):1628–1633. https://doi.org/10.1023/A:1016236932339
Prajapati V, Jain A, Jain R, Sahu S, Kohli DV (2014) Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes. Drug Deliv Transl Res 4(5-6):400–408. https://doi.org/10.1007/s13346-014-0202-2
Prasanthi D, Lakshmi P (2012a) Development of ethosomes with taguchi robust design-based studies for transdermal delivery of alfuzosin hydrochloride. Int Curr Pharm J 1(11):370–375. https://doi.org/10.3329/icpj.v1i11.12063
Prasanthi D, Lakshmi P (2012b) Vesicles-mechanism of transdermal permeation: a review. Asian J Pharm Clin Res 5(1):18–25
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26(11):1261–1268. https://doi.org/10.1038/nbt.1504
Prausnitz MR, Mitragotri S, Langer R (2004) Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3(2):115–124. https://doi.org/10.1038/nrd1304
Puglia C, Bonina F, Rizza L, Cortesi R, Merlotti E, Drechsler M, Mariani P, Contado C, Ravani L, Esposito E (2010) Evaluation of percutaneous absorption of naproxen from different liposomal formulations. J Pharm Sci 99(6):2819–2829. https://doi.org/10.1002/jps.22028
Puri R, Jain S (2012) Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study. Anticancer Drugs 23(9):923–934. https://doi.org/10.1097/CAD.0b013e3283534051
Pyatski Y, Zhang Q, Mendelsohn R, Flach CR (2016) Effects of permeation enhancers on flufenamic acid delivery in Ex vivo human skin by confocal Raman microscopy. Int J Pharm 505(1-2):319–328. https://doi.org/10.1016/j.ijpharm.2016.04.011
Qumbar M, Ameeduzzafar ISS, Ali J, Ahmad J, Ali A (2017) Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: in-vitro characterization and in-vivo activity. Biomed Pharmacother 93:255–266. https://doi.org/10.1016/j.biopha.2017.06.043
Rai S, Pandey V, Rai G (2017) Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. Nano Reviews & Experiments 8(1):1325708. https://doi.org/10.1080/20022727.2017.1325708
Rakesh R, Anoop KR (2012) Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium. J Pharm Bioallied Sci 4(4):333–340. https://doi.org/10.4103/0975-7406.103274
Randhawa MA, Gondal MA, Al-Zahrani AH, Rashid SG, Ali A (2015) Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm. J Environ Sci Health A Tox Hazard Subst Environ Eng 50(2):119–124. https://doi.org/10.1080/10934529.2015.975042
Rao Y, Zheng F, Zhang X, Gao J, Liang W (2008) In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS PharmSciTech 9(3):860–865. https://doi.org/10.1208/s12249-008-9124-y
Raza K, Singh B, Lohan S, Sharma G, Negi P, Yachha Y, Katare OP (2013) Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm 456(1):65–72. https://doi.org/10.1016/j.ijpharm.2013.08.019
Roy SD, Gutierrez M, Flynn GL, Cleary GW (1996) Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design. J Pharm Sci 85(5):491–495. https://doi.org/10.1021/js950415w
Ruozi B, Riva G, Belletti D, Tosi G, Forni F, Mucci A, Barozzi P, Luppi M, Vandelli MA (2010) Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma. Eur J Pharm Sci 41(2):254–264. https://doi.org/10.1016/j.ejps.2010.06.012
Sala M, Diab R, Elaissari A, Fessi H (2017) Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications. Int J Pharm 535(1–2):1–17. https://doi.org/10.1016/j.ijpharm.2017.10.046
Sala M, Diab R, Elaissari A, Fessi H (2018) Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications. Int J Pharm 535(1–2):1–17. https://doi.org/10.1016/j.ijpharm.2017.10.046
Salah S, Mahmoud AA, Kamel AO (2017) Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies. Drug Deliv 24(1):846–856. https://doi.org/10.1080/10717544.2017.1326539
Saraf S, Gupta D, Kaur CD, Saraf S (2011) Sphingosomes a novel approach to vesicular drug delivery. Int J Cur Sci Res 1(2):63–68
Sarwa KK, Suresh PK, Rudrapal M, Verma VK (2014) Penetration of tamoxifen citrate loaded ethosomes and liposomes across human skin: a comparative study with confocal laser scanning microscopy. Curr Drug Deliv 11(3):332–337. https://doi.org/10.2174/1567201811666140115113127
Scheuplein RJ (1965) Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility. J Invest Dermatol 45(5):334–346. https://doi.org/10.1038/jid.1965.140
Scheuplein RJ, Blank IH (1971) Permeability of the skin. Physiol Rev 51(4):702–747. https://doi.org/10.1152/physrev.1971.51.4.702
Schieren H, Rudolph S, Finkelstein M, Coleman P, Weissmann G (1978) Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses. Biochim Biophys Acta 542(1):137–153
Schiffelers RM, Storm G, ten Kate MT, Stearne-Cullen LET, den Hollander JG, Verbrugh HA, Bakker-Woudenberg IAJM (2002) Liposome-enabled synergistic interaction of antimicrobial agents. J Liposome Res 12(1-2):121–127. https://doi.org/10.1081/LPR-120004784
Sharma A, Arora S (2012) Formulation and in vitro evaluation of ufasomes for dermal administration of methotrexate. ISRN Pharm 2012:873653. https://doi.org/10.5402/2012/873653
Sherry M, Charcosset C, Fessi H, Greige-Gerges H (2013) Essential oils encapsulated in liposomes: a review. J Liposome Res 23(4):268–275. https://doi.org/10.3109/08982104.2013.819888
Shilpa S, Srinivasan B, Chauhan M (2011) Niosomes as vesicular carriers for delivery of proteins and biologicals. Int J Drug Deliv 3(1):14–24
Shreya AB, Managuli RS, Menon J, Kondapalli L, Hegde AR, Avadhani K, Shetty PK, Amirthalingam M, Kalthur G, Mutalik S (2016) Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations. J Liposome Res 26(3):221–232. https://doi.org/10.3109/08982104.2015.1098659
Singh D, Pradhan M, Nag M, Singh MR (2015) Vesicular system: versatile carrier for transdermal delivery of bioactives. Artif Cells Nanomed Biotechnol 43(4):282–290. https://doi.org/10.3109/21691401.2014.883401
Singla SK, Sachdeva V (2015) Current and emerging lipid-based systems for transdermal drug delivery. Ther Deliv 6(9):1063–1070. https://doi.org/10.4155/tde.15.66
Sinha VR, Kaur MP (2000) Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26(11):1131–1140. https://doi.org/10.1081/DDC-100100984
Sinico C, Fadda AM (2009) Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 6(8):813–825. https://doi.org/10.1517/17425240903071029
Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM (2005) Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle–skin interaction. J Control Release 103(1):123–136. https://doi.org/10.1016/j.jconrel.2004.11.020
Sintov AC, Krymberk I, Daniel D, Hannan T, Ze S, Levin G (2003) Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J Control Release 89(2):311–320. https://doi.org/10.1016/S0168-3659(03)00123-8
Sloan KB, Wasdo S (2003) Designing for topical delivery: prodrugs can make the difference. Med Res Rev 23(6):763–793. https://doi.org/10.1002/med.10048
Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD (2012) A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces 92:299–304. https://doi.org/10.1016/j.colsurfb.2011.12.004
Steed JW, Turner DR, Wallace K (2007) Core concepts in supramolecular chemistry and nanochemistry. Wiley, West Sussex
Sugiura S, Kuroiwa T, Kagota T, Nakajima M, Sato S, Mukataka S, Walde P, Ichikawa S (2008) Novel method for obtaining homogeneous giant vesicles from a monodisperse water-in-oil emulsion prepared with a microfluidic device. Langmuir 24(9):4581–4588. https://doi.org/10.1021/la703509r
Szoka F Jr, Papahadjopoulos D (1980) Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng 9:467–508. https://doi.org/10.1146/annurev.bb.09.060180.002343
Tanner T, Marks R (2008) Delivering drugs by the transdermal route: review and comment. Skin Res Technol 14(3):249–260. https://doi.org/10.1111/j.1600-0846.2008.00316.x
Teaima MH, Abdelhalim SA, El-Nabarawi MA, Attia DA, Helal DA (2018) Non-ionic surfactant based vesicular drug delivery system for topical delivery of caffeine for treatment of cellulite: design, formulation, characterization, histological anti-cellulite activity, and pharmacokinetic evaluation. Drug Dev Ind Pharm 44(1):158–171. https://doi.org/10.1080/03639045.2017.1386206
Thomas BJ, Finnin BC (2004) The transdermal revolution. Drug Discovery Today 9(16):697–703. https://doi.org/10.1016/S1359-6446(04)03180-0
Touitou E (1996) Compositions for applying active substances to or through the skin. Patent US 5540934A
Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000a) Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65(3):403–418. https://doi.org/10.1016/S0168-3659(99)00222-9
Touitou E, Godin B (2005) Enhanced skin permeation using ethosomes. In: Smith EW, Maibach HI (eds) Percutaneous penetration enhancers, 2nd edn. CRC Press, New York
Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F (2001) Intracellular delivery mediated by an ethosomal carrier. Biomaterials 22(22):3053–3059. https://doi.org/10.1016/S0142-9612(01)00052-7
Touitou E, Godin B, Weiss C (2000b) Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev Res 50(3-4):406–415. https://doi.org/10.1002/1098-2299(200007/08)50:3/4<406::AID-DDR23>3.0.CO;2-M
Trauer S, Richter H, Kuntsche J, Buttemeyer R, Liebsch M, Linscheid M, Fahr A, Schafer-Korting M, Lademann J, Patzelt A (2014) Influence of massage and occlusion on the ex vivo skin penetration of rigid liposomes and invasomes. Eur J Pharm Biopharm 86(2):301–306. https://doi.org/10.1016/j.ejpb.2013.11.004
Trotta M, Peira E, Carlotti ME, Gallarate M (2004) Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270(1-2):119–125. https://doi.org/10.1016/j.ijpharm.2003.10.006
Uchegbu IF, Vyas SP (1998) Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172(1):33–70. https://doi.org/10.1016/S0378-5173(98)00169-0
Valenta C, Siman U, Kratzel M, Hadgraft J (2000) The dermal delivery of lignocaine: influence of ion pairing. Int J Pharm 197(1):77–85. https://doi.org/10.1016/S0378-5173(99)00453-6
van der Merwe D, Brooks JD, Gehring R, Baynes RE, Monteiro-Riviere NA, Riviere JE (2006) A physiologically based pharmacokinetic model of organophosphate dermal absorption. Toxicol Sci 89(1):188–204. https://doi.org/10.1093/toxsci/kfj014
van Swaay D, deMello A (2013) Microfluidic methods for forming liposomes. Lab Chip 13(5):752–767. https://doi.org/10.1039/C2LC41121K
Vanlerberghe G, Handjani-Vila R (1975) Process for the production of dispersions of lipidic droplets in water and new compositions based on same. Patent CA 1063908.
Varshosaz J, Pardakhty A, Baharanchi SM (2005) Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Deliv 12(2):75–82. https://doi.org/10.1080/10717540490446044
Vemuri S, Rhodes CT (1995) Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm Acta Helv 70(2):95–111
Verma DD, Verma S, Blume G, Fahr A (2003) Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258(1):141–151. https://doi.org/10.1016/S0378-5173(03)00183-2
Verma S, Singh S, Syan N, Mathur P, Valecha V (2010) Nanoparticle vesicular systems: a versatile tool for drug delivery. J Chem Pharm Res 2(2):496–509
Vora B, Khopade AJ, Jain NK (1998) Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release 54(2):149–165. https://doi.org/10.1016/S0168-3659(97)00100-4
Waddad AY, Abbad S, Yu F, Munyendo WLL, Wang J, Lv H, Zhou J (2013) Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. Int J Pharm 456(2):446–458. https://doi.org/10.1016/j.ijpharm.2013.08.040
Walker RB, Smith EW (1996) The role of percutaneous penetration enhancers. Adv Drug Deliv Rev 18(3):295–301. https://doi.org/10.1016/0169-409X(95)00078-L
Walters KA (2002) Dermatological and transdermal formulations. CRC Press, New York/London
Walters KA, Walker M, Olejnik O (1988) Non-ionic surfactant effects on hairless mouse skin permeability characteristics. J Pharm Pharmacol 40(8):525–529. https://doi.org/10.1111/j.2042-7158.1988.tb05295.x
Wang J, Wei Y, Fei YR, Fang L, Zheng HS, Mu CF, Li FZ, Zhang YS (2017) Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride. Int J Pharm 533(1):266–274. https://doi.org/10.1016/j.ijpharm.2017.09.059
Wang Y, Su W, Li Q, Li C, Wang H, Li Y, Cao Y, Chang J, Zhang L (2013) Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery. Int J Pharm 441(1):748–756. https://doi.org/10.1016/j.ijpharm.2012.10.019
Watkinson AC, Kearney MC, Quinn HL, Courtenay AJ, Donnelly RF (2016) Future of the transdermal drug delivery market – have we barely touched the surface? Expert Opin Drug Deliv 13(4):523–532. https://doi.org/10.1517/17425247.2016.1130034
Webb MS, Bally MB, Mayer LD (1996) Sphingosomes for enhanced drug delivery. Patent US 5814335 A.
Weiner AL (1994) Liposomes for protein delivery: selecting manufacture and development processes. Immunomethods 4(3):201–209
Wilson V, Siram K, Rajendran S, Sankar V (2017) Development and evaluation of finasteride loaded ethosomes for targeting to the pilosebaceous unit. Artif Cells Nanomed Biotechnol 31:1–10. https://doi.org/10.1080/21691401.2017.1396221
Xia F, Jin H, Zhao Y, Guo X (2012) Preparation of coenzyme Q10 liposomes using supercritical anti-solvent technique. J Microencapsul 29(1):21–29. https://doi.org/10.3109/02652048.2011.629742
Xu S, Zhao B, He D (2015) Synthesis of highly dispersed nanoscaled CoQ10 liposome by supercritical fluid. Materials Lett 142(Suppl C):283–286. https://doi.org/10.1016/j.matlet.2014.12.070
Yan G, Li SK, Higuchi WI (2005) Evaluation of constant current alternating current iontophoresis for transdermal drug delivery. J Control Release 110(1):141–150. https://doi.org/10.1016/j.jconrel.2005.09.006
Yatvin MB, Lelkes PI (1982) Clinical prospects for liposomes. Med Phys 9(2):149–175. https://doi.org/10.1118/1.595079
Yokomizo Y, Sagitani H (1996a) The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers. J Control Release 42(1):37–46. https://doi.org/10.1016/0168-3659(96)01349-1
Yokomizo Y, Sagitani H (1996b) Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pigs in vitro. J Control Release 38(2):267–274. https://doi.org/10.1016/0168-3659(95)00127-1
Yoshida PA, Yokota D, Foglio MA, Rodrigues RA, Pinho SC (2010) Liposomes incorporating essential oil of Brazilian cherry (Eugenia uniflora L.): characterization of aqueous dispersions and lyophilized formulations. J Microencapsul 27(5):416–425. https://doi.org/10.3109/02652040903367327
Yu X, Du L, Li Y, Fu G, Jin Y (2015) Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. Biomed Pharmacother 73:6–11. https://doi.org/10.1016/j.biopha.2015.05.002
Yu Z, Lv H, Han G, Ma K (2016) Ethosomes loaded with cryptotanshinone for acne treatment through topical gel formulation. PLoS One 11(7):e0159967. https://doi.org/10.1371/journal.pone.0159967
Zellmer S, Pfeil W, Lasch J (1995) Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim Biophys Acta Biomembr 1237(2):176–182. https://doi.org/10.1016/0005-2736(95)00100-H
Zhai Y, Zhai G (2014) Advances in lipid-based colloid systems as drug carrier for topic delivery. J Control Release 193:90–99. https://doi.org/10.1016/j.jconrel.2014.05.054
Zhang Y, Zhang K, Wu Z, Guo T, Ye B, Lu M, Zhao J, Zhu C, Feng N (2015) Evaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake. Int J Pharm 478(1):138–146. https://doi.org/10.1016/j.ijpharm.2014.11.018
Zhao Y-Z, Lu C-T, Zhang Y, Xiao J, Zhao Y-P, Tian J-L, Xu Y-Y, Feng Z-G, Xu C-Y (2013) Selection of high efficient transdermal lipid vesicle for curcumin skin delivery. Int J Pharm 454(1):302–309. https://doi.org/10.1016/j.ijpharm.2013.06.052
Zhaowu Z, Xiaoli W, Yangde Z, Nianfeng L (2009) Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J Liposome Res 19(2):155–162. https://doi.org/10.1080/08982100902722381
Zhou W, Liu W, Zou L, Liu W, Liu C, Liang R, Chen J (2014) Storage stability and skin permeation of vitamin C liposomes improved by pectin coating. Colloids Surf B Biointerfaces 117:330–337. https://doi.org/10.1016/j.colsurfb.2014.02.036
Zidan AS, Hosny KM, Ahmed OA, Fahmy UA (2016) Assessment of simvastatin niosomes for pediatric transdermal drug delivery. Drug Deliv 23(5):1536–1549. https://doi.org/10.3109/10717544.2014.980896
Zidan AS, Mokhtar Ibrahim M, Megrab NAE (2017) Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability. Drug Dev Ind Pharm 43(9):1450–1459. https://doi.org/10.1080/03639045.2017.1318907
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kassem, A.A., Abd El-Alim, S.H. (2021). Vesicular Nanocarriers: A Potential Platform for Dermal and Transdermal Drug Delivery. In: Yata, V., Ranjan, S., Dasgupta, N., Lichtfouse, E. (eds) Nanopharmaceuticals: Principles and Applications Vol. 2. Environmental Chemistry for a Sustainable World, vol 47. Springer, Cham. https://doi.org/10.1007/978-3-030-44921-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-44921-6_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-44920-9
Online ISBN: 978-3-030-44921-6
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)